Fig. 4. Concentration–inhibition curves of hit compound 1 (Ki 1110 ± 40 nM, n = 3) and the most potent NPP3 inhibitor of the present series, compound 23 (Ki 53.7 ± 3.1 nM, n = 3) at human NPP3 determined vs. ATP as a substrate.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.